Chirurgie des métastases hépatiques dans le cancer colorectal : but ou moyen ?

Journal de Chirurgie Viscérale - Tập 148 - Trang S6-S10 - 2011
F. Di Fiore1, P. Pessaux2,3
1Unité d’oncologie digestive, Département d’hépato-gastroentérologie, CHU de Rouen, du Nord-Ouest Cancéropôle – Charles Nicolle 1 rue de Germont 76038 Rouen, France
2Pôle des Pathologies Digestives, Hépatiques et de la Transplantation, Hôpital de Hautepierre – Hôpitaux Universitaires de Strasbourg – Université de Strasbourg, avenue Molière, 67200 Strasbourg, France
3Service de chirurgie digestive et hépato-biliaire, CHU Strasbourg, France

Tài liệu tham khảo

Hurwitz, 2004, Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer, N Engl J Med, 350, 2335, 10.1056/NEJMoa032691 Cunningham, 2004, Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer, N Engl J Med, 351, 337, 10.1056/NEJMoa033025 Nordlinger, 2008, Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial, Lancet, 371, 1007, 10.1016/S0140-6736(08)60455-9 Folprecht, 2005, Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates, Ann Oncol, 16, 1311, 10.1093/annonc/mdi246 Falcone, 2007, J Clin Oncol, 25, 1670, 10.1200/JCO.2006.09.0928 Masi, 2010, Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial, Lancet Oncol, 11, 845, 10.1016/S1470-2045(10)70175-3 Folprecht, 2010, Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial, Lancet Oncol, 11, 38, 10.1016/S1470-2045(09)70330-4 Seymour, 2007, Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced cancer (MRC FOCUS): a randomised controlled trial, Lancet, 370, 143, 10.1016/S0140-6736(07)61087-3 Köhne, 2009, Chemotherapy with targeted agents for the treatment of metastatic colorectal cancer, Oncologist, 14, 478, 10.1634/theoncologist.2008-0202 Bismuth, 1996, Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy, Ann Surg, 224, 509, 10.1097/00000658-199610000-00009 Curley, 1999, Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients, Ann Surg, 230, 1, 10.1097/00000658-199907000-00001 Elias, 2006, The trans-metastasis hepatectomy (through metastases previously ablated with radiofrequency): results of a 13-case study of colorectal cancer, J Surg Oncol, 93, 8, 10.1002/jso.20391 Jaeck, 2004, A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases, Ann Surg, 240, 1037, 10.1097/01.sla.0000145965.86383.89 Adam, 2000, Two-stage hepatectomy: a planed stategy to treat irresectable liver tumors, Ann Surg, 232, 777, 10.1097/00000658-200012000-00006 Adam, 2007, Two-stage hepatectomy approach for initially unresectable colorectal hepatic metastases, Surg Oncol Clin N Am, 16, 525, 10.1016/j.soc.2007.04.016 Pessaux, 2009, Advantages of the first-step totally laparoscopic approach in 2-staged hepatectomy for colorectal synchronous liver metastasis, Surgery, 145, 453, 10.1016/j.surg.2008.09.016